Androlabs is a fast growing global men’s health platform officially launched in May 2022. We are already commercialised across over 20 countries, and growing!
Men are often under diagnosed and under-treated. This is at a time where assumptions that men live shorter lives are being questioned, and countries like Australia and Ireland are developing long-term Men's Health specific strategies.
The Androlabs team are excited to officially launch today. In partnership with its sister company Simple Pharma, Androlabs manufactures and commercialises medicines that are indicated to treat conditions that primarily or exclusively affect men. The two companies are working together to rethink the traditional approach to the pharmaceutical industry. Androlabs is focused on providing men with the tools to discuss, prevent and treat their conditions, at each stage of their life.
Androlabs is initially endowed with two prescription-only medicines, Testavan®, a testosterone gel for the treatment of testosterone deficit, and Vitaros®, an alprostadil cream for the treatment of erectile dysfunction. The Androlabs team are actively looking to expand our areas of focus to include other therapy areas and tools.
Androlabs is actively looking to expand in other ways too - the team (headquartered in London but with a presence across more than 20 countries) has just published a number of open roles on their new website. Androlabs are also expanding the number and quality of relationships with key opinion leads and patient advocacy groups globally.
If you are interested in improving outcomes for men, or in how Androlabs are helping to keep men healthy, please contact the Androlabs team below: